TABLE 3

Tissue Distribution of [111ln-DTPA-d-Phe1]Octreotide in Wild-Type and sst2 Knockout Mice

TissueWild typesst2 knockout
Without blockadeWith blockadeWithout blockadeWith blockade
Pituitary gland1.2 ± 0.20.25 ± 0.04*0.033 ± 0.0370.19 ± 0.03
Adrenals0.26 ± 0.030.12 ± 0.04*0.045 ± 0.0200.11 ± 0.03
Thymus0.30 ± 0.050.061 ± 0.020*0.017 ± 0.0030.039 ± 0.010*
Pancreas0.18 ± 0.030.035 ± 0.008*0.007 ± 0.0020.014 ± 0.005
Spleen0.048 ± 0.0080.074 ± 0.0210.075 ± 0.0060.072 ± 0.016
Liver0.090 ± 0.0070.19 ± 0.050.11 ± 0.010.15 ± 0.03
Kidneys1.4 ± 0.31.9 ± 0.42.4 ± 0.52.3 ± 1.1
Soft tissue0.004 ± 0.0010.010 ± 0.0060.003 ± 0.0000.009 ± 0.002
Blood0.004 ± 0.0010.10 ± 0.000.005 ± 0.0010.011 ± 0.004
  • * P < 0.01 for [111ln-DTPA-d-Phe1]octreotide vs. [111ln-DTPA-d-Phe1]octreotide with blockade.

  • P < 0.01 for [111ln-DTPA-d-Phe1]octreotide wild type vs. [111ln-DTPA-d-Phe1]octreotide sst2 knockout.

  • P < 0.05 for [111ln-DTPA-d-Phe1]octreotide vs. [111ln-DTPA-d-Phe1]octreotide with blockade.

  • Values are mean ± SD percentage injected dose per gram of tissue (n = 4 animals per group). Blockade means coinjection of 100 μg octreotide with [111ln-DTPA-d-Phe1]octreotide.